Separation process
US-2024287118-A1 · Aug 29, 2024 · US
US9816122B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9816122-B2 |
| Application number | US-201314430930-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2013 |
| Priority date | Sep 25, 2012 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a non-sugar moiety selected from the group consisting of amino acids, peptides, proteins, lipids, longer alkyl groups, polyethylene glycols, α,β-unsaturated amido group and polyvinyl alcohols, using a genetically modified cell.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a polyethylene glycol, the method comprising: (i) providing a genetically modified cell comprising a gene encoding a glycosyl transferase enzyme that is able to transfer the glycosyl residue of an activated sugar nucleotide to an internalized acceptor and a gene encoding the E. coli lactose permease, (ii) culturing said genetically modified cell in the presence of an exogenous acceptor according to formula 7 wherein n is an integer from 2 to 6, inducing (a) internalization of the exogenous acceptor by the genetically modified cell, and (b) formation of said glycoconjugate from said internalized acceptor molecule by a glycosyl transfer mediated by said glycosyl transferase enzyme expressed by said cell, and then (iii) collecting said glycoconjugate from the fermentation broth. 2. The method according claim 1 , wherein said genetically modified cell provided in step (i) further comprises a set of genes encoding enzymes responsible for the synthesis of said activated sugar nucleotide by a de novo pathway, and wherein said culturing step (ii) further induces producing said activated sugar nucleotide by a de novo pathway. 3. The method according to claim 1 , wherein said glycosyl transferase enzyme is selected from the group consisting of N-acetyl-glucosaminyl transferases, galactosyl transferases, N-acetyl-galactosaminyl transferases, glucuronosyl transferases, sialyl transferases and fucosyl transferases. 4. The method according to claim 3 , wherein said glycosyl transferase enzyme is α-1,2-fucosyl transferase. 5. The method according to claim 3 , wherein said glycosyl transferase enzyme is selected from the group consisting of β-1,3-N-acetyl-glucosaminyl transferase, β-1,6-N-acetyl-glucosaminyl transferase, β-1,3-galactosyl transferase, β-1,4-galactosyl transferase, α-2,3-sialyl transferase, α-2,6-sialyl transferase, α-1,2-fucosyl transferase, α-1,3-fucosyl transferase and α-1,4-fucosyl transferase. 6. The method according to claim 1 , wherein the genetically modified cell is a bacterium or yeast. 7. The method according to claim 1 , wherein the genetically modified cell is E. coli of LacZ − , LacY + genotype, the exogenous acceptor is a lactose covalently linked to a polyethylene glycol, the glycosyl transferase is a fucosyl transferase, and/or a sialyl transferase, and/or an N-acetylglucosaminyl transferase and/or a galactosyl transferase, and the glycoconjugate produced by the method is a fucosylated and/or sialylated and/or N-acetylglucosaminylated and/or galactosylated lactose covalently linked to a polyethylene glycol. 8. The method according to claim 7 , wherein the exogenous acceptor consists of lactose covalently linked to said polyethylene glycol and the glycoconjugate is a fucosylated lactose covalently linked to polyethylene glycol. 9. The method according to claim 7 , wherein the oligosaccharide part of the glycoconjugate is a human milk oligosaccharide. 10. The method according to claim 9 , wherein the human milk oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3-fucosyllactose, difucosyllactose, 3′-sialyllactose, 6′-sialyllactose, 3′-sialyl-3-fucosyllactose, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). 11. The method according to claim 8 , wherein the glycoconjugate is a compound of formula 7a wherein Y is a human milk oligosaccharide glycosyl residue, and n is an integer from 2-6. 12. The method according to claim 11 , wherein n is an integer of from 2 to 4. 13. The method according to claim 11 , wherein the compound of formula 7a is of formula 8d wherein R 1 is fucosyl or H, R 2 is fucosyl or H, n is an integer from 2 to 6, provided that at least one of the R 1 and R 2 groups is fucosyl. 14. The method according to claim 13 , wherein n is an integer of from 2 to 4.
Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title
Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title
attached to an oxygen atom of the saccharide radical · CPC title
having the esterifying carboxyl radicals attached to acyclic carbon atoms · CPC title
Polyoxyalkylene derivatives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.